agent: be avoided in gastroesophageal reflux

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents biological agent
Weight: 0.76
, real estate agent
Weight: 0.65
, source
Weight: 0.64
, contractor
Weight: 0.62
Siblings travel agent
Weight: 0.75
, representative
Weight: 0.67
, beta blocker
Weight: 0.65
, solicitor
Weight: 0.63
, attorney
Weight: 0.62

Related properties

Property Similarity
be avoided in gastroesophageal reflux 1.00
be used in esophageal varices 0.84
cause hyperkalemia 0.80
be contraindicated in pulmonary edema 0.79
be contraindicated in vascular disease 0.79
be contraindicated in peripheral vascular disease 0.79
cause pulmonary edema 0.78
cause hypoglycemia 0.78
be contraindicated in edema 0.78
be contraindicated in diabetes mellitus 0.78

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.11
Rule weight: 0.13
Evidence weight: 0.98
Similarity weight: 0.84
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices)
0.10
Rule weight: 0.13
Evidence weight: 0.98
Similarity weight: 0.80
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.86
¬ Remarkable(beta blocker, cause hyperkalemia)
0.10
Rule weight: 0.13
Evidence weight: 0.98
Similarity weight: 0.79
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema)
0.10
Rule weight: 0.13
Evidence weight: 0.98
Similarity weight: 0.79
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.83
¬ Remarkable(beta blocker, be contraindicated in peripheral vascular disease)
0.10
Rule weight: 0.13
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.72
¬ Remarkable(beta blocker, cause hypoglycemia)
0.10
Rule weight: 0.13
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.68
¬ Remarkable(beta blocker, be contraindicated in diabetes mellitus)

Remarkability from sibling implausibility

0.45
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.80
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.86
Remarkable(beta blocker, cause hyperkalemia) ⋁
Evidence: 0.45
¬ Plausible(beta blocker, cause hyperkalemia)
0.45
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.84
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.73
Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.39
¬ Plausible(beta blocker, be used in esophageal varices)
0.43
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.79
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.83
Remarkable(beta blocker, be contraindicated in peripheral vascular disease) ⋁
Evidence: 0.59
¬ Plausible(beta blocker, be contraindicated in peripheral vascular disease)
0.41
Rule weight: 0.60
Evidence weight: 0.86
Similarity weight: 0.79
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.75
Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.60
¬ Plausible(beta blocker, be contraindicated in pulmonary edema)
0.39
Rule weight: 0.60
Evidence weight: 0.83
Similarity weight: 0.78
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.72
Remarkable(beta blocker, cause hypoglycemia) ⋁
Evidence: 0.64
¬ Plausible(beta blocker, cause hypoglycemia)
0.35
Rule weight: 0.60
Evidence weight: 0.76
Similarity weight: 0.78
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.68
Remarkable(beta blocker, be contraindicated in diabetes mellitus) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in diabetes mellitus)

Salient implies Plausible

0.27
Rule weight: 0.28
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.03
¬ Salient(agent, be avoided in gastroesophageal reflux)

Similarity expansion

0.52
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.78
Evidence: 0.03
Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.22
¬ Remarkable(agent, cause pulmonary edema)
0.49
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.78
Evidence: 0.03
Salient(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.27
¬ Salient(agent, cause pulmonary edema)
0.43
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.78
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.37
¬ Plausible(agent, cause pulmonary edema)
0.36
Rule weight: 0.85
Evidence weight: 0.54
Similarity weight: 0.78
Evidence: 0.22
Typical(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.59
¬ Typical(agent, cause pulmonary edema)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.03
Salient(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.22
¬ Typical(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.78
Similarity weight: 1.00
Evidence: 0.03
Plausible(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.22
¬ Typical(agent, be avoided in gastroesophageal reflux)

Typicality and Rermarkability incompatibility between siblings

0.11
Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 0.84
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in esophageal varices)
0.11
Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 0.80
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.33
¬ Typical(beta blocker, cause hyperkalemia)
0.11
Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 0.79
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.58
¬ Typical(beta blocker, be contraindicated in pulmonary edema)
0.11
Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 0.79
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.52
¬ Typical(beta blocker, be contraindicated in peripheral vascular disease)
0.10
Rule weight: 0.14
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.64
¬ Typical(beta blocker, cause hypoglycemia)
0.10
Rule weight: 0.14
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.03
¬ Remarkable(agent, be avoided in gastroesophageal reflux) ⋁
Evidence: 0.81
¬ Typical(beta blocker, be contraindicated in diabetes mellitus)